Helix Biopharma Corp Stock Price on December 24, 2024
| HBP Stock | CAD 0.92 0.03 3.37% |
If you're considering investing in Helix Stock, it is important to understand the factors that can impact its price. As of today, the current price of Helix BioPharma stands at 0.92, as last reported on the 4th of January, with the highest price reaching 0.92 and the lowest price hitting 0.92 during the day. As of now, Helix Stock is out of control. Helix BioPharma Corp holds Efficiency (Sharpe) Ratio of 5.0E-4, which attests that the entity had a 5.0E-4% return per unit of risk over the last 3 months. We have found twenty-seven technical indicators for Helix BioPharma Corp, which you can use to evaluate the volatility of the firm. Please check out Helix BioPharma's Market Risk Adjusted Performance of 0.0167, downside deviation of 7.93, and Risk Adjusted Performance of 0.0094 to validate if the risk estimate we provide is consistent with the expected return of 0.0041%.
Helix Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Helix |
Sharpe Ratio = 5.0E-4
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | HBP |
Estimated Market Risk
| 8.59 actual daily | 76 76% of assets are less volatile |
Expected Return
| 0.0 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.0 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Helix BioPharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Helix BioPharma by adding Helix BioPharma to a well-diversified portfolio.
Helix BioPharma Valuation on December 24, 2024
It is possible to determine the worth of Helix BioPharma on a given historical date. On December 24, 2024 Helix was worth 0.97 at the beginning of the trading date compared to the closed value of 0.97. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Helix BioPharma stock. Still, in general, we apply an absolute valuation method to find Helix BioPharma's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Helix BioPharma where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Helix BioPharma's related companies.
| Open | High | Low | Close | Volume | |
| 0.97 | 0.97 | 0.97 | 0.97 | 1.00 | |
12/24/2024 | 0.97 | 0.97 | 0.97 | 0.97 | 1.00 |
| 0.97 | 0.97 | 0.97 | 0.97 | 1.00 |
| Backtest Helix BioPharma | | | Helix BioPharma History | | | Helix BioPharma Valuation | Previous | Next |
Helix BioPharma Trading Date Momentum on December 24, 2024
| On December 27 2024 Helix BioPharma Corp was traded for 0.97 at the closing time. The maximum traded price for the trading interval was 0.97 and the lowest daily price was 0.97 . There was no trading activity during the period 1.0. Lack of trading volume on 27th of December 2024 did not cause price change. The trading delta at closing time to the closing price today is 5.15% . |
Helix BioPharma Corp Fundamentals Correlations and Trends
By evaluating Helix BioPharma's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Helix BioPharma's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Helix financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Helix BioPharma Stock history
Helix BioPharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Helix is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Helix BioPharma Corp will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Helix BioPharma stock prices may prove useful in developing a viable investing in Helix BioPharma
Helix BioPharma Corp., an immune-oncology company, focuses on the development of cancer drugs in Canada. Helix BioPharma Corp. is headquartered in Richmond Hill, Canada. HELIX BIOPHARM operates under Biotechnology classification in Canada and is traded on Toronto Stock Exchange. It employs 22 people.
Helix BioPharma Stock Technical Analysis
Helix BioPharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Helix BioPharma Period Price Range
Low | January 4, 2025
| High |
0.00 | 0.00 |
Helix BioPharma Corp cannot be verified against its exchange. Please verify the symbol is currently traded on Toronto Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Helix BioPharma January 4, 2025 Market Strength
Market strength indicators help investors to evaluate how Helix BioPharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Helix BioPharma shares will generate the highest return on investment. By undertsting and applying Helix BioPharma stock market strength indicators, traders can identify Helix BioPharma Corp entry and exit signals to maximize returns
Helix BioPharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Helix BioPharma's price direction in advance. Along with the technical and fundamental analysis of Helix Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Helix to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0094 | |||
| Jensen Alpha | 0.005 | |||
| Total Risk Alpha | (0.14) | |||
| Sortino Ratio | (0) | |||
| Treynor Ratio | 0.0067 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Other Information on Investing in Helix Stock
Helix BioPharma financial ratios help investors to determine whether Helix Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Helix with respect to the benefits of owning Helix BioPharma security.